Sai Life Sciences CFO sees scope for further margin improvement

Krishnam Raju Kanumuri, Managing Director and CEO, and Sivaramakrishnan Chittor, CFO of Sai Life Sciences, said the company will use the IPO proceeds to strengthen the balance sheet and invest in growth.

Leave a Reply

Your email address will not be published. Required fields are marked *